title: Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells.
abstract: Persistent immune activation is a hallmark of chronic viremic HIV-1 infection. Activation of cells of the innate immune system, such as NK cells, occurs rapidly upon infection, and is sustained throughout the course of the disease. However, the precise underlying mechanism accounting for the persistent HIV-1-induced activation of NK cells is poorly understood. In this study, we assessed the role of uridine-rich ssRNA derived from the HIV-1 long terminal repeat (ssRNA40) on activation of NK cells via TLR7/8. Although dramatic activation of NK cells was observed following stimulation of PBMC with ssRNA40, negligible activation was observed following stimulation of purified NK cells despite their expression of TLR8 mRNA and protein. The functional activation of NK cells by this HIV-1-encoded TLR7/8 ligand could not be reconstituted with exogenous IL-12, IFN-alpha, or TNF-alpha, but was critically dependent on the direct contact of NK cells with plasmacytoid dendritic cells or CD14(+) monocytes, indicating an important level of NK cell cross-talk and regulation by accessory cells during TLR-mediated activation. Coincubation of monocyte/plasmacytoid dendritic cells, NK cells, and ssRNA40 potentiated NK cell IFN-gamma secretion in response to MHC-devoid target cells. Studies using NK cells derived from individuals with chronic HIV-1 infection demonstrated a reduction of NK cell responsiveness following stimulation with TLR ligands in viremic HIV-1 infection. These data demonstrate that HIV-1-derived TLR ligands can contribute to the immune activation of NK cells and may play an important role in HIV-1-associated immunopathogenesis and NK cell dysfunction observed during acute and chronic viremic HIV-1 infection.
authors.affiliation: Partners AIDS Research Center, Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02129, USA.
authors.forename: Galit
authors.initials: G
authors.lastname: Alter
authors.forename: Todd J
authors.initials: TJ
authors.lastname: Suscovich
authors.forename: Nickolas
authors.initials: N
authors.lastname: Teigen
authors.forename: Angela
authors.initials: A
authors.lastname: Meier
authors.forename: Hendrik
authors.initials: H
authors.lastname: Streeck
authors.forename: Christian
authors.initials: C
authors.lastname: Brander
authors.forename: Marcus
authors.initials: M
authors.lastname: Altfeld
mesh_terms: D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008024:Ligands; D008213:Lymphocyte Activation; D018655:Lymphocyte Count; D009000:Monocytes / Q000276:immunology; D012367:RNA, Viral / Q000737:chemistry / Q000276:immunology* / Q000494:pharmacology; D051199:Toll-Like Receptor 7 / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D051200:Toll-Like Receptor 8 / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D014529:Uridine / Q000032:analysis; D014766:Viremia / Q000276:immunology*
chemical_list: D016207:Cytokines; D008024:Ligands; D012367:RNA, Viral; D051199:Toll-Like Receptor 7; D051200:Toll-Like Receptor 8; D014529:Uridine